Compare CubeSmart (CUBE) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CubeSmart vs Revvity Inc — how do they compare? CubeSmart trades at $37.74 (market cap $8.45B), while Revvity Inc trades at $154.95 (market cap $16.98B). The key difference: Revvity Inc is far larger — about 2× CubeSmart's market cap, and CubeSmart pays the higher dividend (5.65%). Which is the better fit depends on your goals — on Pluang, investors hold CubeSmart for 89 Days and Revvity Inc for 12 Days on average.
| CUBE | RVTY | |
|---|---|---|
Market Cap | $8.45B | $16.98B |
Volume | 2,879,532 | 1,456,900 |
Sector | Real Estate | Health |
52-Week High | $42.50 | $157.36 |
52-Week Low | $35.36 | $82.26 |
Typical Hold Time | 89 Days | 12 Days |
Enterprise Value | $11.97B | $19.30B |
Dividend Yield | 5.65% | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CubeSmart (CUBE) trades at $37.73, up 1.34% with mixed technical signals showing bearish moving averages but neutral oscillators. The REIT maintains strong profitability with 29.41% net margins and consistent dividend payments. Recent Q2 2026 earnings showed operational improvement with revenue beats but FFO misses, prompting raised full-year guidance. Institutional activity remains active with several major funds increasing positions in Q2 2026.
CUBE presents a balanced opportunity with 17% upside to consensus target but faces headwinds from moderating earnings growth and high leverage. The stock offers a 5.4% dividend yield while trading at reasonable valuations (P/E 25.5). Key risks include REIT sector pressure and ongoing macroeconomic uncertainty affecting self-storage demand.
Revvity (RVTY) trades at $154.33, up 0.48% on the day and near its 52-week high of $158.28. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and positive analyst upgrades reflect solid fundamentals. Key developments include the launch of a new Type 1 diabetes screening kit in Europe and the acquisition of Human Cell Design to bolster metabolic disease research, signaling growth in diagnostics and life sciences.
The outlook remains positive given consistent earnings outperformance and strategic expansions, though rich valuation multiples pose a risk if growth moderates. Investors face near-term headwinds from margin pressures in China and elevated P/E ratios, but institutional accumulation and a lack of sell ratings support a constructive bias for long-term holders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CubeSmart
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. CubeSmart derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
Read more on CUBE →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
